Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Haemonetics Corporation (HAE) had Debt to Equity Ratio of 0.94 for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
$1.17B |
|
$115.40M |
|
$553.56M |
|
$615.10M |
|
$1.01B |
|
$156.03M |
|
$-14.63M |
|
$141.40M |
|
$141.40M |
|
$115.40M |
|
$115.40M |
|
$115.40M |
|
$115.40M |
|
$156.03M |
|
$251.31M |
|
50.78M |
|
51.42M |
|
$2.27 |
|
$2.24 |
|
| Balance Sheet Financials | |
$769.72M |
|
$310.88M |
|
$1.17B |
|
$1.93B |
|
$251.82M |
|
$754.10M |
|
$865.01M |
|
$1.12B |
|
$818.00M |
|
$76.00M |
|
$818.00M |
|
50.45M |
|
| Cash Flow Statement Financials | |
$273.06M |
|
$-143.79M |
|
$-100.36M |
|
$259.50M |
|
$284.47M |
|
$24.97M |
|
$25.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.06 |
|
-- |
|
-- |
|
0.48 |
|
|
Debt to Equity Ratio |
0.94 |
52.63% |
|
13.35% |
|
13.35% |
|
21.50% |
|
12.10% |
|
9.87% |
|
$164.47M |
|
-- |
|
-- |
|
-- |
|
0.60 |
|
2.13 |
|
6.52 |
|
55.95 |
|
14.11% |
|
151.85% |
|
5.96% |
|
7.34% |
|
$16.21 |
|
$3.20 |
|
$5.31 |
|